推荐产品
等級
pharmaceutical primary standard
API 家族
vinorelbine
製造商/商標名
EDQM
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
−70°C
InChI
1S/C45H54N4O8.2C4H6O6/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7;2*5-1(3(7)8)2(6)4(9)10/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3;2*1-2,5-6H,(H,7,8)(H,9,10)/t28?,37-,38+,39+,42+,43+,44-,45-;2*1-,2-/m011/s1
InChI 密鑰
CILBMBUYJCWATM-NPJYPKOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Vinorelbine tartrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
包裝
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他說明
Sales restrictions may apply.
訊號詞
Danger
危險分類
Acute Tox. 2 Oral - Carc. 2 - Muta. 2 - Repr. 1B - STOT RE 1
儲存類別代碼
6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Development and Validation of New RPHPLC Method for the Estimation of Vinorelbine in Pharmaceutical Dosage Forms.
International Journal of Research in Pharmacy and Chemistry, 201(3), 3-3 (2013)
Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
Internal medicine (Tokyo, Japan), 40(8), 779-782 (2001)
Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Fundamental & Clinical Pharmacology, 19(5), 545-553 (2005)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门